Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue, net $ 9,078 $ 8,189 $ 29,931 $ 23,506
Cost of revenue 4,124 3,457 12,163 10,286
Gross profit 4,954 4,732 17,768 13,220
Operating expenses:        
Sales and marketing 2,498 2,236 7,444 6,987
Research and development 149 191 484 626
General and administrative 2,124 2,767 7,515 8,636
Acquisition related amortization expense 199 318 834 953
Change in fair value of contingent consideration (311)
Total operating expenses 4,970 5,512 16,277 16,891
Operating (loss) income from continuing operations (16) (780) 1,491 (3,671)
Interest accretion expense (26) (38) (92) (123)
Note payable interest (230) (230) (682) (620)
Other expense, net (252) (217) (408) (20)
(Loss) income from continuing operations before tax (524) (1,265) 309 (4,434)
Provision (benefit) for income taxes 4 (11) 12 24
(Loss) income from continuing operations (528) (1,254) 297 (4,458)
Loss from discontinued operations, net of tax (86) (12,954) (385) (15,936)
Net loss $ (614) $ (14,208) $ (88) $ (20,394)
Basic income (loss) per share of common stock:        
From continuing operations $ (0.12) $ (0.30) $ 0.07 $ (1.05)
From discontinued operations (0.02) (3.05) (0.09) (3.77)
Net loss per basic and diluted share of common stock (0.14) (3.35) (0.02) (4.82)
Diluted income (loss) per share of common stock:        
From continuing operations (0.12) (0.30) 0.07 (1.05)
From discontinued operations (0.02) (3.05) (0.09) (3.77)
Net loss per basic and diluted share of common stock $ (0.14) $ (3.35) $ (0.02) $ (4.82)
Weighted average number of common shares and common share equivalents outstanding:        
Basic 4,319 4,242 4,313 4,227
Diluted 4,319 4,242 4,355 4,227